Related Experiment Videos
[Therapeutic strategy for pleural mesothelioma]
1Second Department of Surgery, Fukuoka University School of Medicine, Japan.
Nihon Geka Gakkai Zasshi
|July 10, 1998
Summary
Pleural mesothelioma, a cancer of the lung lining, has localized (benign) and diffuse (malignant) types. Current treatments lack a cure for malignant mesothelioma, but gene therapy offers future hope.
Area of Science:
- Oncology
- Pathology
- Thoracic Surgery
Context:
- Pleural mesothelioma is histologically classified into localized and diffuse types.
- Localized forms are typically benign, while diffuse forms are malignant.
- Malignant pleural mesothelioma presents significant therapeutic challenges.
Purpose:
- To review the current treatment strategies for pleural mesothelioma.
- To highlight the limitations of existing therapeutic approaches.
- To identify promising future directions in mesothelioma treatment.
Summary:
- Treatment strategies for pleural mesothelioma encompass surgical interventions and chemotherapy.
- Despite extensive research, no definitive cure exists for malignant pleural mesothelioma.
- Gene therapy is emerging as a potentially powerful future treatment modality.
Impact:
- This review underscores the urgent need for novel and effective treatments for malignant pleural mesothelioma.
- It highlights the potential of gene therapy to revolutionize mesothelioma treatment.
- Advances in understanding mesothelioma subtypes can guide personalized therapeutic strategies.